Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 2,252 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum sold 2,252 shares of the stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $41,481.84. Following the completion of the sale, the executive vice president now directly owns 103,862 shares of the company’s stock, valued at $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Privia Health Group Price Performance

Shares of PRVA stock traded up $0.38 during trading hours on Thursday, reaching $18.41. 782,205 shares of the company were exchanged, compared to its average volume of 940,409. Privia Health Group, Inc. has a fifty-two week low of $17.54 and a fifty-two week high of $30.15. The stock’s fifty day moving average is $19.67 and its two-hundred day moving average is $21.16. The company has a market cap of $2.18 billion, a price-to-earnings ratio of 96.90, a P/E/G ratio of 2.51 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The company had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. Privia Health Group’s revenue for the quarter was up 21.0% on a year-over-year basis. On average, research analysts anticipate that Privia Health Group, Inc. will post 0.26 earnings per share for the current year.

Wall Street Analyst Weigh In

PRVA has been the subject of a number of recent research reports. Bank of America lowered Privia Health Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $27.00 to $21.00 in a research note on Thursday, February 22nd. Truist Financial cut their target price on Privia Health Group from $32.00 to $28.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Stifel Nicolaus cut their target price on Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday. TD Cowen cut their target price on Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a research note on Friday, March 1st. Finally, JPMorgan Chase & Co. cut their target price on Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 6th. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $27.62.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently modified their holdings of the stock. Capstone Investment Advisors LLC lifted its position in shares of Privia Health Group by 32.3% during the first quarter. Capstone Investment Advisors LLC now owns 51,454 shares of the company’s stock worth $1,008,000 after purchasing an additional 12,575 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Privia Health Group by 18.2% during the first quarter. Janney Montgomery Scott LLC now owns 60,306 shares of the company’s stock worth $1,181,000 after buying an additional 9,286 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Privia Health Group by 9.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after buying an additional 756 shares during the last quarter. Riverbridge Partners LLC raised its stake in shares of Privia Health Group by 17.5% during the first quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock worth $105,779,000 after buying an additional 804,304 shares during the last quarter. Finally, Peregrine Capital Management LLC raised its stake in shares of Privia Health Group by 26.3% during the first quarter. Peregrine Capital Management LLC now owns 281,879 shares of the company’s stock worth $5,522,000 after buying an additional 58,640 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.